Duyuru • Aug 14
U.S. Physical Therapy, Inc. Announces Appointment of Nchacha Etta to Executive Vice President, Effective September 1, 2026 U.S. Physical Therapy, Inc. announced that Nchacha Etta will serve as the Executive Vice President, effective as of September 1, 2026. Mr. Etta brings significant experience, most recently serving as Executive Vice President and Chief Financial Officer of Omnicell, Inc. from 2023 to 2025, and Senior Vice President and Chief Financial Officer for Essilor of America, Inc. from 2019 through 2022. Before those roles, Mr. Etta served as the Worldwide Vice President and Chief Financial Officer of Johnson & Johnson Vision from 2015 to 2019, and for the previous nine years, he held various senior finance roles at The Coca-Cola Company. Earlier in his career, Mr. Etta worked at Microsoft Corporation, Eli Lilly & Company and The Carlyle Group. Mr. Etta received a Bachelor of Science degree in Accounting from George Mason University, and an MBA in Finance from Howard University. He has served as a member of the board of directors of KBR, Inc. since 2024 and is a member of its Audit Committee and Sustainability, Technology and Cybersecurity Committee. Declared Dividend • Aug 10
Second quarter dividend of US$0.46 announced Shareholders will receive a dividend of US$0.46. Ex-date: 21st August 2026 Payment date: 11th September 2026 Dividend yield will be 2.4%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (dividend approximately 10x earnings). However, it is well covered by cash flows (43% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 1,052% to bring the payout ratio under control. EPS is expected to grow by 374% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio. Reported Earnings • Aug 06
Second quarter 2026 earnings released: EPS: US$0.66 (vs US$0.58 in 2Q 2025) Second quarter 2026 results: EPS: US$0.66 (up from US$0.58 in 2Q 2025). Revenue: US$211.9m (up 8.5% from 2Q 2025). Net income: US$9.90m (up 12% from 2Q 2025). Profit margin: 4.7% (up from 4.5% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 12% per year, which means it is performing significantly worse than earnings. Duyuru • Aug 06
U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 11, 2026 The Board of Directors of U.S. Physical Therapy, Inc. declared a quarterly dividend of $0.46 which will be payable on September 11, 2026 to shareholders of record on August 21, 2026. New Risk • Jul 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (358% payout ratio). Share price has been volatile over the past 3 months (8.0% average weekly change). Profit margins are more than 30% lower than last year (1.0% net profit margin). Duyuru • Jul 08
U.S. Physical Therapy, Inc. to Report Q2, 2026 Results on Aug 06, 2026 U.S. Physical Therapy, Inc. announced that they will report Q2, 2026 results on Aug 06, 2026 Duyuru • May 08
U.S. Physical Therapy, Inc. announces Quarterly dividend, payable on June 12, 2026 U.S. Physical Therapy, Inc. announced Quarterly dividend of USD 0.4600 per share payable on June 12, 2026, ex-date on May 22, 2026 and record date on May 22, 2026. Duyuru • Apr 23
U.S. Physical Therapy, Inc. to Report Q1, 2026 Results on May 06, 2026 U.S. Physical Therapy, Inc. announced that they will report Q1, 2026 results After-Market on May 06, 2026 Duyuru • Apr 17
U.S. Physical Therapy, Inc., Annual General Meeting, May 19, 2026 U.S. Physical Therapy, Inc., Annual General Meeting, May 19, 2026. Location: 1300 west sam houston parkway south, suite 300, houston 77042, texas United States Duyuru • Feb 02
U.S. Physical Therapy, Inc. to Report Fiscal Year 2025 Results on Feb 25, 2026 U.S. Physical Therapy, Inc. announced that they will report fiscal year 2025 results on Feb 25, 2026 Duyuru • Nov 19
U.S. Physical Therapy, Inc. (NYSE:USPH) announces an Equity Buyback for $25 million worth of its shares. U.S. Physical Therapy, Inc. (NYSE:USPH) announces a share repurchase program. Under the program, the company will repurchase up to $25 million worth of its shares. Duyuru • Nov 06
U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 12, 2025 U.S. Physical Therapy, Inc. Board of Directors declared a quarterly dividend of $0.45 per share payable on December 12, 2025, to shareholders of record on November 17, 2025. Duyuru • Oct 21
U.S. Physical Therapy, Inc. to Report Q3, 2025 Results on Nov 06, 2025 U.S. Physical Therapy, Inc. announced that they will report Q3, 2025 results on Nov 06, 2025 Duyuru • Aug 07
U.S. Physical Therapy, Inc. Declares A Quarterly Dividend, Payable on September 12, 2025 U.S. Physical Therapy, Inc.’s Board of Directors declared a quarterly dividend of $0.45 per share payable on September 12, 2025, to shareholders of record on August 22, 2025. Duyuru • Jul 23
U.S. Physical Therapy, Inc. to Report Q2, 2025 Results on Aug 06, 2025 U.S. Physical Therapy, Inc. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025 Duyuru • May 23
U.S. Physical Therapy, Inc. Announces Appointment of Michael G. Mayrsohn as Director U.S. Physical Therapy, Inc. announced that at its AGM held on May 20, 2025, the shareholders approved appointment of Michael G. Mayrsohn as Director. Duyuru • May 08
U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on June 13, 2025 The Board of Directors of U.S. Physical Therapy, Inc. declared a quarterly dividend of $0.45 per share payable on June 13, 2025, to shareholders of record on May 23, 2025. Duyuru • Apr 23
U.S. Physical Therapy, Inc. to Report Q1, 2025 Results on May 07, 2025 U.S. Physical Therapy, Inc. announced that they will report Q1, 2025 results After-Market on May 07, 2025 Duyuru • Apr 14
U.S. Physical Therapy, Inc., Annual General Meeting, May 20, 2025 U.S. Physical Therapy, Inc., Annual General Meeting, May 20, 2025. Location: 1300 west sam houston parkway south, suite 300, texas 77042, houston United States Duyuru • Feb 27
U.S. Physical Therapy, Inc. Raises Quarterly Dividend and Declares Quarterly Dividend for the First Quarter of 2025, Payable on April 11, 2025 The Board of Directors of U.S. Physical Therapy, Inc. raised the Company’s quarterly dividend rate from $0.44 per share to $0.45 per share, effective immediately, and declared a quarterly dividend for the first quarter of 2025 at the higher rate. The dividend will be payable on April 11, 2025, to shareholders of record on March 14, 2025. Duyuru • Feb 10
U.S. Physical Therapy, Inc. to Report Q4, 2024 Results on Feb 27, 2025 U.S. Physical Therapy, Inc. announced that they will report Q4, 2024 results on Feb 27, 2025 Recent Insider Transactions • Nov 13
President & COO recently sold €179k worth of stock On the 8th of November, Eric Williams sold around 2k shares on-market at roughly €89.34 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Eric has been a net seller over the last 12 months, reducing personal holdings by €566k. Declared Dividend • Nov 12
Third quarter dividend of US$0.44 announced Shareholders will receive a dividend of US$0.44. Ex-date: 15th November 2024 Payment date: 6th December 2024 Dividend yield will be 1.9%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (187% earnings payout ratio). However, it is well covered by cash flows (36% cash payout ratio). The dividend has increased by an average of 14% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 107% to bring the payout ratio under control. EPS is expected to grow by 96% over the next 2 years, which means the dividend may need to be reduced to reach a sustainable payout ratio. Reported Earnings • Nov 10
Third quarter 2024 earnings released: EPS: US$0.39 (vs US$0.51 in 3Q 2023) Third quarter 2024 results: EPS: US$0.39 (down from US$0.51 in 3Q 2023). Revenue: US$166.3m (up 12% from 3Q 2023). Net income: US$5.81m (down 23% from 3Q 2023). Profit margin: 3.5% (down from 5.1% in 3Q 2023). Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Duyuru • Nov 06
U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024 U.S. Physical Therapy, Inc. announced that Board of Directors declared a quarterly dividend of $0.44 per share payable on December 6, 2024, to shareholders of record on November 15, 2024. Duyuru • Oct 24
U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024 U.S. Physical Therapy, Inc. announced that they will report Q3, 2024 results After-Market on Nov 05, 2024 Duyuru • Aug 14
U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024 U.S. Physical Therapy, Inc. declared a quarterly dividend of $0.44 per share payable on September 13, 2024, to shareholders of record on August 23, 2024. Duyuru • Aug 10
U.S. Physical Therapy, Inc. announced delayed 10-Q filing On 08/09/2024, U.S. Physical Therapy, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Duyuru • Jul 26
U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024 U.S. Physical Therapy, Inc. announced that they will report Q2, 2024 results After-Market on Aug 13, 2024 Buy Or Sell Opportunity • Jun 05
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 6.3% to €89.50. The fair value is estimated to be €113, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has declined by 19%. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 182% in the next 2 years. Recent Insider Transactions • May 30
Chairman & CEO recently sold €196k worth of stock On the 29th of May, Christopher Reading sold around 2k shares on-market at roughly €93.55 per share. This transaction amounted to 2.1% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €253k. This was Christopher's only on-market trade for the last 12 months. Recent Insider Transactions • May 15
Chief Operating Officer - East recently sold €242k worth of stock On the 10th of May, Eric Williams sold around 3k shares on-market at roughly €96.77 per share. This transaction amounted to 13% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €253k. Insiders have been net sellers, collectively disposing of €2.4m more than they bought in the last 12 months. Declared Dividend • May 13
First quarter dividend of US$0.44 announced Shareholders will receive a dividend of US$0.44. Ex-date: 22nd May 2024 Payment date: 14th June 2024 Dividend yield will be 1.7%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (144% earnings payout ratio). However, it is well covered by cash flows (40% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 60% to bring the payout ratio under control. EPS is expected to grow by 126% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. Reported Earnings • May 08
First quarter 2024 earnings released: EPS: US$0.54 (vs US$0.58 in 1Q 2023) First quarter 2024 results: EPS: US$0.54. Revenue: US$154.0m (up 4.8% from 1Q 2023). Net income: US$8.05m (up 7.3% from 1Q 2023). Profit margin: 5.2% (up from 5.1% in 1Q 2023). Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Healthcare industry in Germany. Duyuru • Apr 16
U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024 U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024, at 09:00 Central Standard Time. Location: 1300 West Sam Houston Parkway South, Suite 300, Houston, Texas 77042 Texas United States Agenda: To consider election of seven directors to serve until the next annual meeting of stockholders; to Advisory vote to approve named executive officer compensation; to Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2024; and to consider other matters if any. Recent Insider Transactions • Mar 06
Chief Operating Officer - West recently sold €253k worth of stock On the 4th of March, Graham Reeve sold around 3k shares on-market at roughly €96.11 per share. This transaction amounted to 9.5% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €2.0m more than they bought in the last 12 months. Declared Dividend • Mar 04
Fourth quarter dividend of US$0.44 announced Shareholders will receive a dividend of US$0.44. Ex-date: 11th March 2024 Payment date: 5th April 2024 Dividend yield will be 1.7%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (135% earnings payout ratio). However, it is well covered by cash flows (36% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 49% to bring the payout ratio under control. EPS is expected to grow by 116% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. New Risk • Mar 01
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.0% Last year net profit margin: 5.3% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (135% payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.0% net profit margin). Shareholders have been diluted in the past year (15% increase in shares outstanding). Duyuru • Feb 29
U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024 U.S. Physical Therapy, Inc. increased the quarterly dividend on February 27, 2024, from $0.43 per share to $0.44 per share. The Board of Directors subsequently declared a quarterly dividend of $0.44 per share payable on April 5, 2024, to shareholders of record on March 12, 2024. New Risk • Feb 29
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (15% increase in shares outstanding). Reported Earnings • Feb 29
Full year 2023 earnings released: EPS: US$1.99 (vs US$2.25 in FY 2022) Full year 2023 results: EPS: US$1.99 (down from US$2.25 in FY 2022). Revenue: US$598.6m (up 9.3% from FY 2022). Net income: US$28.2m (down 3.5% from FY 2022). Profit margin: 4.7% (down from 5.3% in FY 2022). Revenue is forecast to grow 5.8% p.a. on average during the next 2 years, while revenues in the Healthcare industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Buy Or Sell Opportunity • Feb 15
Now 21% undervalued Over the last 90 days, the stock has risen 8.1% to €86.50. The fair value is estimated to be €110, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has declined by 5.6%. Revenue is forecast to grow by 13% in 2 years. Earnings are forecast to grow by 100% in the next 2 years. Duyuru • Feb 07
U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024 U.S. Physical Therapy, Inc. announced that they will report Q4, 2023 results After-Market on Feb 28, 2024 Buying Opportunity • Dec 18
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 7.9%. The fair value is estimated to be €103, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has declined by 5.6%. Revenue is forecast to grow by 13% in 2 years. Earnings is forecast to grow by 100% in the next 2 years. Reported Earnings • Nov 09
Third quarter 2023 earnings released: EPS: US$0.62 (vs US$0.72 in 3Q 2022) Third quarter 2023 results: EPS: US$0.62 (down from US$0.72 in 3Q 2022). Revenue: US$150.0m (up 8.5% from 3Q 2022). Net income: US$9.25m (down 1.7% from 3Q 2022). Profit margin: 6.2% (down from 6.8% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 1.3% decline forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has fallen by 4% per year and the company’s share price has also fallen by 4% per year. Duyuru • Nov 08
U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023 On November 6, 2023, the U.S. Physical Therapy, Inc.'s Board of Directors declared a quarterly dividend of $0.43 per share payable on December 8, 2023, to shareholders of record on November 16, 2023. Duyuru • Oct 14
U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023 U.S. Physical Therapy, Inc. announced that they will report Q3, 2023 results After-Market on Nov 07, 2023 Recent Insider Transactions • Aug 15
Chief Operating Officer - West recently sold €413k worth of stock On the 11th of August, Graham Reeve sold around 4k shares on-market at roughly €100 per share. This transaction amounted to 16% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €5.4m more than they bought in the last 12 months. Reported Earnings • Aug 09
Second quarter 2023 earnings released: EPS: US$0.80 (vs US$0.87 in 2Q 2022) Second quarter 2023 results: EPS: US$0.80 (down from US$0.87 in 2Q 2022). Revenue: US$149.9m (up 7.8% from 2Q 2022). Net income: US$10.9m (down 3.8% from 2Q 2022). Profit margin: 7.3% (down from 8.2% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Duyuru • Aug 09
U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023 U.S. Physical Therapy, Inc. declared a quarterly dividend of $0.43 per share payable on September 8, 2023 to shareholders of record on August 18, 2023. Duyuru • Aug 02
U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million. U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million on August 1, 2023. USPH acquired a 70% equity interest in the practice for a purchase price of $2.1 million, with the current practice owners retaining a 30% equity interest. The business currently generates approximately $2.4 million in annual revenues.U.S. Physical Therapy, Inc. (NYSE:USPH) completed the acquisition of a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) on August 1, 2023. Duyuru • Jul 23
U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023 U.S. Physical Therapy, Inc. announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Aug 08, 2023 Duyuru • Jun 01
U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million on May 31, 2023. Current practice owners retaining a 25% equity interest. The business currently generates approximately $2.6 million in annual revenues.U.S. Physical Therapy, Inc. (NYSE:USPH) completed the acqsuitiion of 75% interest in Physical therapy practice with four clinics on May 31, 2023. Duyuru • May 26
U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million. U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 1,666,667
Price\Range: $90
Discount Per Security: $4.5 Duyuru • May 17
U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors U.S. Physical Therapy, Inc. announced that Ms. Nancy Ham was elected to serve on the Company’s Board of Directors (“Board”) during the Company’s Annual Shareholders’ Meeting held on May 16, 2023, with her service effective on the same date. Ms. Ham is the former Chief Executive Officer and Director of WebPT, a national provider of billing systems and electronic medical record solutions, where she served in such roles from 2016 through 2021. Prior to WebPT, from 2005 through 2016, Ms. Ham served as Chief Executive Officer and/or President of four companies involved in various aspects of the health care technology industry, serving hospitals, rehabilitation providers and health plans. Ms. Ham currently serves as a director of HST Pathways, a leading provider of software solutions to health care providers, Blue Cross Blue Shield of Arizona, a health insurance company, and Power Wellness, a medical fitness company. She is also an Advisory Board Member of Madison Dearborn Partners, LLC, a private equity firm focused on healthcare technology services, HLM Ventures, a venture capital firm also focused on health care technology services, and LRV Health, a venture capital firm focused on health care technology. Upcoming Dividend • May 10
Upcoming dividend of US$0.43 per share at 1.6% yield Eligible shareholders must have bought the stock before 17 May 2023. Payment date: 09 June 2023. Payout ratio is on the higher end at 77%, however this is supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (3.1%). Duyuru • May 05
U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023 The Board of Directors of U.S. Physical Therapy, Inc. declared a quarterly dividend of $0.43 per share payable on June 9, 2023, to shareholders of record on May 18, 2023. Reported Earnings • May 04
First quarter 2023 earnings released: EPS: US$0.57 (vs US$0.67 in 1Q 2022) First quarter 2023 results: EPS: US$0.57 (down from US$0.67 in 1Q 2022). Revenue: US$147.0m (up 13% from 1Q 2022). Net income: US$7.41m (down 15% from 1Q 2022). Profit margin: 5.0% (down from 6.7% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.4% p.a. on average during the next 2 years, compared to a 3.9% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions • Mar 17
Independent Director recently sold €439k worth of stock On the 15th of March, Bernard Harris sold around 5k shares on-market at roughly €87.78 per share. This transaction amounted to 24% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €5.2m more than they bought in the last 12 months. Recent Insider Transactions • Mar 05
Executive VP recently sold €87k worth of stock On the 2nd of March, Richard Binstein sold around 911 shares on-market at roughly €95.04 per share. This transaction amounted to 8.4% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €573k. Insiders have been net sellers, collectively disposing of €4.9m more than they bought in the last 12 months. Upcoming Dividend • Mar 02
Upcoming dividend of US$0.43 per share at 1.7% yield Eligible shareholders must have bought the stock before 09 March 2023. Payment date: 07 April 2023. Payout ratio is a comfortable 73% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (3.4%). Reported Earnings • Feb 24
Full year 2022 earnings released: EPS: US$2.25 (vs US$2.42 in FY 2021) Full year 2022 results: EPS: US$2.25 (down from US$2.42 in FY 2021). Revenue: US$547.6m (up 12% from FY 2021). Net income: US$29.3m (down 6.0% from FY 2021). Profit margin: 5.3% (down from 6.4% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.4% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 1% per year. Duyuru • Feb 01
U.S. Physical Therapy, Inc. to Report Q4, 2022 Results on Feb 22, 2023 U.S. Physical Therapy, Inc. announced that they will report Q4, 2022 results After-Market on Feb 22, 2023 Recent Insider Transactions • Dec 20
Independent Director recently sold €573k worth of stock On the 16th of December, Harry Chapman sold around 7k shares on-market at roughly €80.06 per share. This transaction amounted to 52% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €858k. Insiders have been net sellers, collectively disposing of €4.9m more than they bought in the last 12 months. Recent Insider Transactions • Dec 06
President recently sold €858k worth of stock On the 2nd of December, Christopher Reading sold around 10k shares on-market at roughly €85.84 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Christopher has been a net seller over the last 12 months, reducing personal holdings by €1.9m. Duyuru • Dec 02
U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice from practice’s owners for $25 million. U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice from practice’s owners for $25 million on November 30, 2022. Practice’s owners retain 20% stake in Thirteen-clinic physical therapy practice. The business currently generates more than $12 million in annualized revenue and approximately 120,000 annualized patient visits.
U.S. Physical Therapy, Inc. (NYSE:USPH) completed the acquisition of 80% stake in Thirteen-clinic physical therapy practice from practice’s owners on November 30, 2022. Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 1 experienced director. 7 highly experienced directors. Independent Director Anne Motsenbocker was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Nov 11
Upcoming dividend of US$0.41 per share Eligible shareholders must have bought the stock before 18 November 2022. Payment date: 16 December 2022. Payout ratio is a comfortable 54% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (4.0%). Recent Insider Transactions • Nov 09
Chief Operating Officer - West recently sold €162k worth of stock On the 7th of November, Graham Reeve sold around 2k shares on-market at roughly €84.81 per share. This transaction amounted to 7.9% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €397k. Insiders have been net sellers, collectively disposing of €2.9m more than they bought in the last 12 months. Buying Opportunity • Nov 04
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 4.9%. The fair value is estimated to be €113, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.0% over the last 3 years. Earnings per share has grown by 7.6%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 7.7% in the next 2 years. Reported Earnings • Nov 03
Third quarter 2022 earnings released: EPS: US$0.73 (vs US$0.66 in 3Q 2021) Third quarter 2022 results: EPS: US$0.73 (up from US$0.66 in 3Q 2021). Revenue: US$138.3m (up 11% from 3Q 2021). Net income: US$9.56m (up 13% from 3Q 2021). Profit margin: 6.9% (up from 6.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Duyuru • Oct 11
U.S. Physical Therapy, Inc. to Report Q3, 2022 Results on Nov 03, 2022 U.S. Physical Therapy, Inc. announced that they will report Q3, 2022 results Pre-Market on Nov 03, 2022 Duyuru • Oct 04
U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Two-Clinic Physical Therapy Practice for $4.2 million. U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Two-Clinic Physical Therapy Practice for $4.2 million on October 3, 2022. USPH acquired 80% of the equity interests of the physical therapy practice with the practice’s owners retaining 20%. The purchase price for the 80% equity interest was approximately $4.2 million inclusive of a note payable to the owners of $250,000. The remainder was paid in cash. Two-Clinic Physical Therapy Practice generates more than $2.5 million in annual revenue.
U.S. Physical Therapy, Inc. (NYSE:USPH) completed the acquisition of 80% stake in Two-Clinic Physical Therapy Practice on October 3, 2022. Recent Insider Transactions • Sep 08
Director recently bought €78k worth of stock On the 6th of September, Reginald Swanson bought around 1k shares on-market at roughly €78.39 per share. This transaction amounted to 6.7% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth €82k. Despite this recent purchase, insiders have collectively sold €1.9m more in shares than they bought in the last 12 months. Duyuru • Sep 02
U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in six-clinic physical therapy practice in West Virginia and Pennsylvania for $3.5 million. U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in six-clinic physical therapy practice in West Virginia and Pennsylvania for $3.5 million on September 1, 2022. The practice’s founder and owners will be retaining 30% of the stake. The business generates more than $2.5 million in annual revenue and has approximately 26,000 patient visits per year.
U.S. Physical Therapy, Inc. (NYSE:USPH) completed the acquisition of a 70% stake in six-clinic physical therapy practice in West Virginia and Pennsylvania on September 1, 2022. Recent Insider Transactions • Aug 27
Independent Director recently bought €82k worth of stock On the 24th of August, Kathleen Gilmartin bought around 1k shares on-market at roughly €81.89 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold €2.5m more in shares than they bought in the last 12 months. Recent Insider Transactions • Aug 10
Independent Director recently bought €54k worth of stock On the 8th of August, Kathleen Gilmartin bought around 600 shares on-market at roughly €90.28 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold €2.4m more in shares than they bought in the last 12 months. Reported Earnings • Aug 05
Second quarter 2022 earnings released: EPS: US$0.86 (vs US$0.82 in 2Q 2021) Second quarter 2022 results: EPS: US$0.86 (up from US$0.82 in 2Q 2021). Revenue: US$139.1m (up 11% from 2Q 2021). Net income: US$11.2m (up 6.2% from 2Q 2021). Profit margin: 8.0% (down from 8.4% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 9.1%, compared to a 2.7% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Duyuru • Aug 05
U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 16, 2022 U.S. Physical Therapy, Inc.'s Board of Directors declared a quarterly dividend of $0.41 per share payable on September 16, 2022, to shareholders of record on August 18, 2022. Duyuru • Jul 13
U.S. Physical Therapy, Inc. to Report Q2, 2022 Results on Aug 04, 2022 U.S. Physical Therapy, Inc. announced that they will report Q2, 2022 results at 9:30 AM, US Eastern Standard Time on Aug 04, 2022 Reported Earnings • May 06
First quarter 2022 earnings released: EPS: US$0.68 (vs US$0.21 in 1Q 2021) First quarter 2022 results: EPS: US$0.68 (up from US$0.21 in 1Q 2021). Revenue: US$130.4m (up 17% from 1Q 2021). Net income: US$8.80m (up 219% from 1Q 2021). Profit margin: 6.7% (up from 2.5% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 10.0%, compared to a 4.7% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Duyuru • May 06
U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on June 14, 2022 U.S. Physical Therapy, Inc.'s Board of Directors declared a quarterly dividend of $0.41 per share payable on June 14, 2022, to shareholders of record on May 16, 2022. Board Change • Apr 27
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 6 highly experienced directors. Independent Director Anne Motsenbocker was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Duyuru • Apr 13
U.S. Physical Therapy, Inc. to Report Q1, 2022 Results on May 05, 2022 U.S. Physical Therapy, Inc. announced that they will report Q1, 2022 results Pre-Market on May 05, 2022 Duyuru • Apr 06
U.S. Physical Therapy, Inc., Annual General Meeting, May 17, 2022 U.S. Physical Therapy, Inc., Annual General Meeting, May 17, 2022, at 09:00 Central Daylight. Location: 1300 West Sam Houston Parkway South Suite 300 Hoston Texas United States Agenda: To consider election of nine directors to serve until the next annual meeting of stockholders ; to consider advisory vote to approve named executive officer compensation; to consider Approval of an amendment to the Amended and Restated 2003 Stock Incentive Plan ; to consider Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2022; to consider of any other matters that may properly come before the meeting or any adjournments. Duyuru • Apr 03
U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in Madden and Gilbert Physical Therapy, LP from Chad Madden, Michael Gilbert and others for $11.5 million. U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in Madden and Gilbert Physical Therapy, LP from Chad Madden, Michael Gilbert and others for $11.5 million on April 1, 2022. USPH acquired 70% of the equity interests of the physical therapy practice with the practice’s founder and owners retaining 30%. The business generates more than $7.5 million in annual revenue.
U.S. Physical Therapy, Inc. (NYSE:USPH) completed the acquisition of a 70% stake in Madden and Gilbert Physical Therapy, LP from Chad Madden, Michael Gilbert and others on April 1, 2022. Recent Insider Transactions • Mar 18
Independent Director recently sold €287k worth of stock On the 15th of March, Harry Chapman sold around 3k shares on-market at roughly €86.54 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €3.5m more than they bought in the last 12 months. Recent Insider Transactions • Mar 09
Chief Operating Officer of East recently sold €171k worth of stock On the 28th of February, Graham Reeve sold around 2k shares on-market at roughly €80.81 per share. In the last 3 months, there was an even bigger sale from another insider worth €999k. Insiders have been net sellers, collectively disposing of €3.4m more than they bought in the last 12 months. Upcoming Dividend • Mar 04
Upcoming dividend of US$0.41 per share Eligible shareholders must have bought the stock before 11 March 2022. Payment date: 08 April 2022. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of German dividend payers (3.4%). Lower than average of industry peers (2.9%). Reported Earnings • Feb 25
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: US$3.17 (up from US$2.48 in FY 2020). Revenue: US$489.7m (up 17% from FY 2020). Net income: US$40.8m (up 28% from FY 2020). Profit margin: 8.3% (up from 7.6% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 4.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Duyuru • Feb 25
U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on April 8, 2022 U.S. Physical Therapy, Inc. announced increased the company’s quarterly dividend on February 22, 2022, from $0.38 per share to $0.41 per share, an increase of 7.9%. The Board of Directors subsequently declared a quarterly dividend of $0.41 per share payable on April 8, 2022 to shareholders of record on March 14, 2022. 
